| 摘要 |
Disclosed are the compounds of general formula (I), wherein Y is phenyl, optionally substituted by hydroxygroup or fluorine and G is 1-pyrolidinyl or piperidine. Pharmaceutical preparation useful for treating or preventing obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease and prostatic disease contains the said tetrahydronaphtol and pharmaceutically acceptable bearer.
|
